← Back to Search

Augmented Visual Feedback for Stroke Rehabilitation

N/A
Recruiting
Led By James Patton
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
8 months post stroke
FMUE 15-50
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4.5 months
Awards & highlights

Study Summary

This trial will study the feasibility and effects of error-augmented visual feedback during motion tracking with a Leap Motion device and the LookingGlass for people with different levels of stroke severity.

Who is the study for?
This trial is for adults who had a stroke at least 8 months ago, can move their shoulder and elbow against gravity to reach forward, but not for those with severe muscle stiffness, recent Botox in the arm, or other rehab treatments. It excludes pregnant women, children, prisoners, people with multiple strokes or severe sensory issues in the limb.Check my eligibility
What is being tested?
The study tests if augmented visual feedback using Leap Motion and Looking Glass helps improve movement more than standard feedback. Participants are divided into healthy individuals; acute stroke survivors (recent stroke); and chronic survivors (older stroke), each receiving different interventions.See study design
What are the potential side effects?
Since this is a non-invasive intervention focusing on motion tracking and visual feedback without drugs or surgery involved, there are no direct side effects expected from the technology itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You had a stroke 8 months ago.
Select...
I'm not familiar with the term "FMUE 15-50." Can you provide more context or information so I can assist you better?
Select...
You are able to move your shoulder and elbow to reach 30 cm in different directions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4.5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4.5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fugl Meyer Upper Extremity Score: Pre to Post/Discharge - Chronic and Acute Arms
Secondary outcome measures
Action Research Arm Test Score: Pre to Follow-Up
Action Research Arm Test Score: Pre to Post
Amount of use
+1 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Chronic Veridical Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Group II: Chronic Augmented Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Group III: Acute Veridical Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Group IV: Acute Augmented Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Group V: HealthyActive Control1 Intervention
Healthy participants will participate in reaching activity using the Looking Glass and Leap motion tracking system

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
192 Previous Clinical Trials
14,810 Total Patients Enrolled
69 Trials studying Stroke
6,270 Patients Enrolled for Stroke
James PattonPrincipal Investigator - Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)
Shirley Ryan AbilityLab

Media Library

Augmented Visual Feedback Clinical Trial Eligibility Overview. Trial Name: NCT03300141 — N/A
Stroke Research Study Groups: Acute Augmented Visual Feedback, Chronic Augmented Visual Feedback, Healthy, Acute Veridical Visual Feedback, Chronic Veridical Visual Feedback
Stroke Clinical Trial 2023: Augmented Visual Feedback Highlights & Side Effects. Trial Name: NCT03300141 — N/A
Augmented Visual Feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT03300141 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Mar 2025